News & Analysis on Clinical Trial Services & Contract Research And Development
Rules governing when drugmakers should warn regulators about supply interruptions need to take mitigation plans into account according to European industry groups.
INTERACTIVE POLL
Competition among small CROs kept prices steady in 2014 despite higher sponsor R&D spending and greater outsourcing penetration, according to a Citi Research survey.
Covance is looking to speed early drug development by setting up teams of experts to help sponsors bridge their preclinical and clinical development.
Teva must invest in its biomanufacturing network as the firm’s biologics aspirations grow beyond biosimilars, CEO Erez Vigodman told investors.
The US National Institutes of Health (NIH) has awarded funding to a third organisation performing early-stage clinical trials of infectious disease drugs.
The EMA has responded to feedback from generic drugmakers by broadening an assessment sharing pilot to regulators outside the EU.
Abenza subsidiary Antitope has extended its relationship and will provide manufacturing cell lines for two developing HIV vaccines from the French National Institute of Health and Medical Research (INSERM); the National Health Agency for Research on AIDS...